Stockreport

Calithera's CB-839 Fast Track'd for advanced kidney cancer [Seeking Alpha]

Calithera Biosciences, Inc.  (CALA) 
Last calithera biosciences, inc. earnings: 3/11 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: calithera.com
PDF Calithera's CB-839 Fast Track'd for advanced kidney cancerThe FDAdesignates Calithera Biosciences' (NASDAQ:CALA) CB-839 for Fast Track review for the treatment, in combi [Read more]